Form 8-K - Current report:
SEC Accession No. 0001655759-24-000140
Filing Date
2024-12-10
Accepted
2024-12-10 09:07:13
Documents
19
Period of Report
2024-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20241210.htm   iXBRL 8-K 35294
2 EX-99.1 ex991-2024x12x10xsabcs20.htm EX-99.1 18180
6 ex991-2024x12x10xsabcs20001.jpg GRAPHIC 259830
7 ex991-2024x12x10xsabcs20002.jpg GRAPHIC 238066
8 ex991-2024x12x10xsabcs20003.jpg GRAPHIC 305918
9 ex991-2024x12x10xsabcs20004.jpg GRAPHIC 301855
10 ex991-2024x12x10xsabcs20005.jpg GRAPHIC 100258
  Complete submission text file 0001655759-24-000140.txt   1853968

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20241210.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20241210_lab.xml EX-101.LAB 23451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20241210_pre.xml EX-101.PRE 13581
21 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20241210_htm.xml XML 2816
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 241537262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)